James Hardie Fires Back at Proxy Advisors Over CEO Pay and Board Fees Ahead of August 20 Vote
JHX sits 83% above its 52-week low of $16.46.
Summary
James Hardie issued a detailed rebuttal to proxy advisors ACSI and ISS, urging shareholders to support the CEO equity grant and an increase to the non-executive director fee pool at the August 20 annual meeting.
Key Events · Corporate Governance and Compliance · JHX
-
Proxy Advisor Opposition
ACSI recommended voting against the CEO Equity Grant (Proposal 4), while ISS recommended against the Increase to Non-Executive Director Fee Pool (Proposal 6).
-
Board Rebuttal on CEO Pay
The board argues the redesigned LTI structure — including removal of the cash-settled Scorecard LTI, introduction of stock options, and use of adjusted EBITDA targets — directly addresses shareholder feedback and aligns with U.S. market practice.
-
Defense of Director Fee Cap Increase
The board states the fee cap has not increased since 2019, and the proposed increase is needed to cover tax equalization payments for non-Irish directors and to attract qualified global board members amid growing complexity.
-
Vote Deadline Approaching
The annual meeting is scheduled for August 20, 2026 (U.S.) / August 21, 2026 (Australia), giving shareholders limited time to consider the board's arguments.
Analysis · JHX · Manufacturing
With its annual meeting just 10 days away, James Hardie is actively defending two key proposals — the CEO's equity grant and an increase to the non-executive director fee pool — after both ACSI and ISS recommended against them. The company argues that the redesigned compensation plan directly addresses shareholder feedback from last year's failed vote, and that the board fee cap increase is necessary to attract global talent and cover tax equalization costs tied to its Irish domicile. This rebuttal signals the board is fighting to secure approval on contentious governance items that could shape executive retention and board composition.
At the time of this filing, JHX was trading at $30.08 on NYSE in the Manufacturing sector, with a market capitalization of approximately $17.7B. The 52-week trading range was $16.46 to $30.99. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.